Wednesday, June 18, 2008

Fighting for generic drug producer Zentiva.

Zentiva is high flying today on Prague Stock Exchange after Sanofi Aventis (SNY) has offered CZK 1050 per share. This takeover bid is higher by 10,5% than offer from investment group PPF. Sanofi Aventis owns already 24,9% stake in Zentiva. It's obvious for PPF that for successful takeover they must increase the offer. Another further bidding will fuel Zentiva shares.

The next thing making bright outlook for Zentiva is acquisition of generic drugs producer in Turkey, EczacibaƟi Generic Pharmaceuticals. Czech company has 75% share.Turkish company already contributes 25% of total revenue. From the country perspective revenue are down on main markets in Czech Republic and Romania. On the other side best performing markets are Russia (+ 19,9 %), Slovakia (+ 14 %) and Poland (+ 11,8 %).
Disclosure: Author owns Zentiva shares.

Comments

2 Responses to "Fighting for generic drug producer Zentiva."

Anonymous said... June 20, 2008 at 10:49 AM

Vlada, correct English is "on the other hand" not "side" as is used by Czech language. Karel

Vlada, Czech Republic said... June 20, 2008 at 7:51 PM

Karel, thanks for correction. This is the disadvantage when non native English speaking blogging in English :)